z-logo
open-access-imgOpen Access
Preliminary studies of acute and sub-chronic toxicity of the aqueous extract of Guibourtia tessmannii (Harms) J. Leonard stem barks (Caesalpiniaceae) in mice and rats
Author(s) -
Noreen Orianna Koumba Madingou,
Aristide Traoré,
Alain Souza,
Marlaine Boukandou Mounanga,
Raissa Reine Aworet Samseny,
Sylvin Ouédraogo,
Alfred S. Traoré
Publication year - 2016
Publication title -
asian pacific journal of tropical biomedicine/asian pacific journal of tropical biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 61
eISSN - 2588-9222
pISSN - 2221-1691
DOI - 10.1016/j.apjtb.2016.04.001
Subject(s) - toxicity , acute toxicity , median lethal dose , body weight , lethal dose , medicine , pharmacology , food intake , oral administration , toxicology , aqueous extract , chronic toxicity , physiology , traditional medicine , biology
ObjectiveTo investigate the toxicity of aqueous extract of Guibourtia tessmannii (Harms) J. Leonard (G. tessmannii) and evaluate its safety.MethodsNMRI mice were used to determine the acute toxicity of G. tessmannii. Increasing concentrations of the plant extracts were administered intraperitoneally or by force-feeding. General behavior and death were monitored and recorded daily for 7 days. In order to determine the sub-acute toxicity of the extract, several doses were administered by oral gavage daily for 28 days in adult Wistar rats. Different parameters were assessed including body weight, food and water intake, biochemical parameters and several vital organ weights.ResultsLD50 of 328.78 mg/kg was obtained by i.p. route and more than 5000 mg/kg was obtained in acute toxicity by oral route. In sub-acute toxicity, no significant alteration was observed in body weight or vital organs, food and water intake, and biochemical parameters.ConclusionsThe results showed that the aqueous extract of G. tessmannii has low toxicity intraperitoneally and no sub-acute toxicity via oral intake

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here